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Abstract: Background Falls represent a major health problem for older adults with cognitive impairment,
and the effects of exercise for fall reduction are understudied in this population. This pilot randomized
controlled trial evaluated the feasibility, safety, and exploratory effectiveness of a Dalcroze eurhythmics
program and a home exercise program designed for fall prevention in older adults with mild cognitive
impairment (MCI) or early dementia. Methods For this three-arm, single-blind, 12-month randomized
controlled pilot trial, we recruited community-dwelling women and men age 65 years and older with
MCI or early dementia through participating memory clinics in Zurich, Switzerland. Participants were
randomly assigned to a Dalcroze eurhythmics group program, a simple home exercise program (SHEP),
or a non-exercise control group. All participants received 800 IU of vitamin D3 per day. The main
objective of the study was to test the feasibility of recruitment and safety of the interventions. Additional
outcomes included fall rate, gait performance, and cognitive function. Results Over 12 months, 221 older
adults were contacted and 159 (72%) were screened via telephone. Following screening, 12% (19/159)
met the inclusion criteria and were willing to participate. One participant withdrew at the end of the
baseline visit and 18 were randomized to Dalcroze eurhythmics (n = 7), SHEP (n = 5), or control (n
= 6). Adherence was similarly low in the Dalcroze eurhythmics group (56%) and in the SHEP group
(62%; p = 0.82). Regarding safety and pilot clinical endpoints, there were no differences between groups.
Conclusion The MOVE for your MIND pilot study showed that recruitment of older adults with MCI or
early dementia for long-term exercise interventions is challenging. While there were no safety concerns,
adherence to both exercise programs was low.
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Abstract
Background: Falls represent a major health problem for older adults with cognitive impairment, and the effects of
exercise for fall reduction are understudied in this population. This pilot randomized controlled trial evaluated the
feasibility, safety, and exploratory effectiveness of a Dalcroze eurhythmics program and a home exercise program
designed for fall prevention in older adults with mild cognitive impairment (MCI) or early dementia.
Methods: For this three-arm, single-blind, 12-month randomized controlled pilot trial, we recruited community-
dwelling women and men age 65 years and older with MCI or early dementia through participating memory clinics
in Zurich, Switzerland. Participants were randomly assigned to a Dalcroze eurhythmics group program, a simple
home exercise program (SHEP), or a non-exercise control group. All participants received 800 IU of vitamin D3 per
day. The main objective of the study was to test the feasibility of recruitment and safety of the interventions.
Additional outcomes included fall rate, gait performance, and cognitive function.
Results: Over 12 months, 221 older adults were contacted and 159 (72%) were screened via telephone. Following
screening, 12% (19/159) met the inclusion criteria and were willing to participate. One participant withdrew at the
end of the baseline visit and 18 were randomized to Dalcroze eurhythmics (n = 7), SHEP (n = 5), or control (n = 6).
Adherence was similarly low in the Dalcroze eurhythmics group (56%) and in the SHEP group (62%; p = 0.82).
Regarding safety and pilot clinical endpoints, there were no differences between groups.
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Conclusion: The MOVE for your MIND pilot study showed that recruitment of older adults with MCI or early
dementia for long-term exercise interventions is challenging. While there were no safety concerns, adherence to
both exercise programs was low.
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Background
Falls are highly prevalent in older adults with every third
person over the age of 65 years experiencing at least one
fall per year [1, 2]. Falls also constitute a significant
health burden as 10–20% of all falls have serious conse-
quences such as fractures, hospitalization, or death [3, 4].
Falls are multifactorial, and major risk factors include
older age, gait and balance impairment, and reduced cog-
nitive function [4, 5]. Regarding the latter, older adults
with mild cognitive impairment (MCI) or dementia have a
twofold higher risk of falling and are twice as likely to ex-
perience severe consequences such as fractures and loss of
autonomy compared to cognitively healthy peers [1, 6].
Exercise is among the most effective strategies for fall
prevention, independent of whether it is performed in a
group setting or at home [7, 8]. Notably, both settings
have been demonstrated to be safe and feasible in older
adults with cognitive impairment or dementia [9–11].
However, results from meta-analyses on the effect of
exercise on fall reduction among older adults with
impaired cognitive function are inconclusive, indicating
that the beneficial effect of certain exercise programs
might not translate to this population [12–14].
Music-based exercise programs stimulate both motor
[15] and cognitive functions [16] and may be particularly
beneficial for cognitively impaired older adults [17].
Dalcroze eurhythmics training is a music-based multi-
task training which appeals to balance and gait func-
tions, but also to concentration, alertness, and executive
functions [18]. In a previous randomized controlled trial,
once weekly participation in a Dalcroze eurhythmics
program reduced fall rate by 54% and significantly im-
proved gait, balance, and executive functions among
cognitively healthy, community-dwelling older adults
[19, 20]. Attending a group exercise intervention outside
the home, such as Dalcroze eurhythmics, requires a cer-
tain level of organizational skills and might therefore not
be feasible for a significant portion of older adults at
early stages of cognitive impairment.
In order to establish feasibility (based on recruitment
rates, adherence, and dropout rates) and to collect pilot
data on the clinical effectiveness of two different exercise
strategies for cognitively impaired older adults, a Dalcroze
eurhythmics program and a simple home exercise pro-
gram (SHEP) were compared to a non-exercise control
group among older adults with MCI or early dementia.
The SHEP has been validated in the Zurich hip fracture
trial and reduced the rate of falls significantly by 25% in
older adults with acute hip fracture with a mean age
of 84 years [21, 22].
Methods
The reporting of this study follows the CONSORT state-
ment for randomized pilot and feasibility trials [23].
Study design
The MOVE for your MIND pilot trial is a 12-month,
single-blind randomized controlled trial, conducted
between August 2014 and September 2016. Participants
were randomly allocated to either Dalcroze eurhythmics
classes (1 × 60 min/week), the SHEP (3 × 30 min/week),
or the control group in a parallel group trial design. All
participants received 800 IU of vitamin D3 per day to
maintain standard of care. The primary endpoints were
feasibility assessed by recruitment rate, adherence, and
safety. Secondary endpoints were rate of falls, gait per-
formance, and cognitive function.
Setting and participants
Participants were recruited from three memory clinics in
Zurich cooperating in the study (City Hospital Waid,
Entlisberg, and Rehalp). Recruitment strategies involved
mailing lists from the three memory clinics as well as
referrals through practicing physicians at the memory
clinics. All memory clinics are members of the Swiss
Memory Clinics Association and therefore apply the
same diagnostic testing which includes physical examin-
ation, extensive neuropsychological testing, pathology
(blood markers), and magnetic resonance imaging. The
diagnosis is made in an interdisciplinary team based on
the results of the testing.
The target sample size was 60 participants; however,
only 18 participants could be enrolled. This study was
therefore defined as an a posteriori pilot trial in order to
address feasibility endpoints for future studies.
Memory clinic patients who had been diagnosed with
MCI or early dementia 12 months prior to the study
start or during the recruitment period were informed
about the study by their attending physician who also
made the decision whether a patient is judicious based
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on the comprehensive diagnostic testing. Participants
were only eligible if confirmed to be able to give in-
formed consent by their attending physician at the mem-
ory clinic. Other study eligibility criteria included age 65
years or older and being sufficiently mobile to come to
the study center and comply with the intervention. Pro-
spective participants who expressed interest in the study
underwent a preliminary eligibility screening over the
phone. Medical records from the memory clinics were
also considered during that initial screening process. If
participants were eligible and willing to participate after
the pre-screening, participants were invited for the
screening and baseline visit. At the beginning of the ini-
tial visit at the study center, a study doctor performed
the final screening interview, which involved the same
questions as the pre-screening interview, to confirm eli-
gibility of the participant.
After we recruited the first eleven participants into the
trial, we changed one eligibility criterion and started to
recruit an informant (e.g., partner, caregiver) for each
participant to ensure reliability of fall reports and to im-
prove adherence to the exercise programs. Key exclusion
criteria were diseases associated with an increased risk
of falling (e.g., Parkinson’s disease, polyneuropathy,
vertigo) or other serious illnesses (e.g., cancer, kidney
failure, coronary heart disease).
The study protocol was approved by the Cantonal Ethics
Committee of Zurich (2014-0110). Written informed con-
sent was obtained from all study participants before any
study-related procedure was conducted. Participant en-
rollment, all examinations, and data collection took place
at the Centre on Aging and Mobility at the University of
Zurich.
Randomization and blinding
Randomization was performed in blocks of six and
stratified by the diagnosis of cognitive impairment (MCI
vs. dementia) and history of falls during the last 12
months (any vs. none). A random allocation number for
each participant was computer-generated by the trial
software.
All study staff members were blinded to treatment al-
location with the exception of two study nurses involved
in the recruitment and organization of the Dalcroze
eurhythmics classes and the physiotherapist, who com-
pleted the randomization and introduced participants to
the treatment allocation, performed instruction of the
SHEP, and assessed adherence to the exercise program.
Interventions
The Dalcroze eurhythmics classes followed a protocol
which was successfully used in a previous study [19].
Classes took place once weekly for 60 min and were
taught by an experienced instructor. Classes were held
every week over the 12-month intervention period (52
weeks) except for public holidays and a short break over
Christmas and summer holidays, amounting to a total of
approximately 47 sessions per year. The exercises included
different courses of motion, sometimes in combination
with the handling of objects (e.g., a ball or claves), per-
formed to the rhythm of piano music. The complexity of
the exercises gradually increased during a session, starting
with single tasks and then combining them into multi-
task exercises. Adherence to the Dalcroze eurhythmics
sessions was recorded by the instructor.
The SHEP was tested in a prior trial among acute hip
fracture patients and included five components: sit-to-
stand, single leg stance (balance component), stair
climbing (functional mobility), pull back, and external
shoulder rotation against elastic resistance [21]. It was
instructed by a physiotherapist at the baseline visit and
adapted to individual needs if necessary. Participants
were provided a booklet with a detailed description and
illustration of the program with the recommendation to
do the exercises three times a week. We also provided a
training diary to record adherence to the exercise pro-
gram. Participants were instructed to perform the exer-
cises three times a week for the entire 12 months.
Based on pre-defined criteria, participants were con-
sidered adherent if they attended 80% of the Dalcroze
eurhythmics classes or if they performed the SHEP at
least once a week on average [21].
Outcome measures
Feasibility of recruitment and the exercise interventions
was assessed by measuring recruitment rate, exercise ad-
herence, and dropout rates. Adverse events were re-
corded to evaluate safety of the trial interventions and
testing procedures.
The study included three clinical visits (baseline and 6
and 12months) which involved physical examination,
medical history, gait analyses, and functional and cogni-
tive tests. Between clinical visits, participants were con-
tacted bi-monthly to record adverse events, adherence to
the SHEP, and falls. Falls were defined as “unintention-
ally coming to rest on the ground, floor, or other lower
level.” Coming to rest against furniture or a wall was not
considered a fall [24]. Incident falls were assessed with a
self-reported diary, at the 6- and 12-month visits and at
the bi-monthly phone calls.
Gait speed and variability of step length and step time
were assessed using the GAITRite® gait analysis system,
a pressure-sensitive walkway of 792 cm length (Platinum
CIR Systems, PA, USA). Participants completed three
single-task walks: walking at preferred speed (referred to
as “normal” gait speed), slow speed, and fast speed.
Then, they performed the dual-task walks: walking at
normal speed while serially subtracting two, starting
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from a pre-defined number (working memory dual-task),
and walking while naming animals (semantic memory
dual-task). Coefficients of variation (CV) were calculated
for step length and step time parameters (CV = [SD/
mean] × 100).
Cognitive function was assessed using the Montreal
Cognitive Assessment (MoCA). The MoCA test consists
of 30 questions evaluating different cognitive abilities.
The score can range from 0 to 30 points, and a score of
≥ 26 is considered normal. In the validation study, the
average score for patients with MCI was 22.1 and 16.2
for people with Alzheimer’s disease [25].
Statistical analyses
Baseline characteristics were compared by treatment
group. We used Fischer exact tests for categorical vari-
ables due to small cell counts. For continuous variables
that had a normal distribution, we used ANOVA F tests,
and for those with high skewness or kurtosis when
stratified by treatment, we used Kruskal-Wallis non-
parametric tests.
Recruitment rate was calculated as the proportion of
participants who were successfully enrolled in the trial
of the total number screened for eligibility. Adherence
rate was defined as the percentage of exercise sessions
completed of the maximum number of sessions they
could have attended during the 12-month intervention
period (100%).
We compared the change of single- and dual-task gait
speed and MoCA over time between the 3 study groups
using a repeated-measures linear mixed model. All ana-
lyses were conducted in SAS 9.4.
Results
Recruitment
Of 221 older adults contacted with possible MCI or early
dementia, 18 were enrolled (Fig. 1) and randomized to
Dalcroze eurhythmics classes (n = 7), SHEP (n = 5), or
control (n = 6). At baseline, nine participants (50%) re-
ported a fall in the 12months prior to enrollment. Base-
line characteristics are shown in Table 1. The mean age
of the study participants was 76.4 ± 4.5 years at baseline,
and the mean MoCA score was 20.6 ± 2.8. None of the
baseline characteristics differed significantly between
treatment groups. However, participants in the Dalcroze
group had slightly lower gait speed for the dual-task
walks. One study participant dropped out of the study
Fig. 1 CONSORT diagram of participant flow
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after 150 days of follow-up because of a hemorrhagic
insult.
Adherence to the study interventions
Adherence to both exercise interventions was low. In
the SHEP group, the average adherence was 62% with
three out of five participants being compliant (trained at
least once per week on average). In the Dalcroze group,
only two out of seven participants were compliant
(attended ≥ 80% of the sessions) and mean adherence
was 56%. The reasons for non-adherence to the exercise
interventions were forgetting about the program, inter-
ference with other activities or therapies, lack of motiv-
ation to leave home, or illness.
Study outcomes
Given the challenges of recruitment and small sample
size, we cannot draw any conclusions regarding the ef-
fectiveness of our interventions based on this pilot study.
Rate of falling
Five falls were reported during the 12-month follow-up
period, one fall occurred in the control group and two
falls in each intervention group.
Gait performance
Analyses for single-task normal gait speed did not sig-
nificantly differ between groups, with a non-significant
improvement from baseline to 12months by 6.5 cm/s
(mean change = + 6.5 cm/s; 95% CI − 18.3, 31.4) for
the SHEP group, a decline by 10 cm/s (mean change =
− 10.0 cm/s; 95% CI − 28.2, 8.3) for the Dalcroze group,
and a decrease of 10.3 cm/s (mean change = − 10.3 cm/s;
95% CI − 31.2, 10.6) for the control group.
Similarly, there was no difference between groups in
gait speed during working memory dual-task from base-
line to 12 months, with a small decrease of 0.9 cm/s
in the Dalcroze group in contrast to a decrease of
39.5 cm/s in the SHEP group and 26.1 cm/s in the control
group. Results for single- and dual-task gait speed are
summarized in Table 2.
Cognitive function
For the change in MoCA from baseline to 12 months,
there was no difference between groups, with a non-
significant decline for both the Dalcroze (− 1.0 points)
and the SHEP (− 1.7 points) groups and a non-
significant improvement in the control group (a 0.6-
point increase) (Table 2).
Safety
Five serious adverse events were reported: one in the
control group (cerebrovascular insult), one in the SHEP
group (hemorrhagic stroke), and three in the Dalcroze
group (partial bowel obstruction, theophylline intoxica-
tion, retinal detachment). None of the events was related
to the interventions, and all participants continued their
participation except for the one who dropped out.
Discussion
The aim of the MOVE for your MIND pilot trial was to
evaluate the feasibility and safety of two exercise strat-
egies, a Dalcroze eurhythmics program or a simple home
exercise program (SHEP), among older adults with MCI
or early dementia. While the results of our study suggest
safety of the interventions, they do not confirm feasibil-
ity with regard to recruitment and adherence in this tar-
get population.
While the desired sample size was 60 participants, only
18 of 220 contacted older adults from 3 memory clinics
could be enrolled in the pilot trial, reflecting a recruit-
ment rate of 8.1%. Recruitment strategies included mail-
ing lists of the recruiting memory clinics of potentially
eligible participants and referrals through practicing
physicians at the memory clinics. Recruitment challenges
included comorbidities such as mobility impairment,
Table 1 Baseline characteristics by treatment group
Variable Dalcroze (n = 7) SHEP (n = 5) Control (n = 6)
Age, years 75.9 (5.1) 73.8 (3.6) 76.7 (4.8)
Female gender, n (%) 4 (57.1) 3 (60.0) 4 (66.7)
Fall history last 12 months, n (%) 4 (57.1) 2 (40.0) 3 (50.0)
Cognitive function
Diagnosis of MCI, n (%) 3 (42.9) 2 (40.0) 1 (16.7)
Diagnosis of mild dementia, n (%) 4 (57.1) 3 (60.0) 5 (83.3)
MoCA score (max. 30) 19.6 (2.9) 22.6 (3.0) 20.0 (1.9)
Gait speed, cm/s
Single task 103.3 (20.8) 104.4 (31.6) 112.0 (13.8)
Dual-task working memory 90.2 (19.0) 114.5 (19.3) 88.3 (17.2)
Dual-task semantic memory 94.5 (73.4–106.5) 128.5 (78.9–149.1) 94.5 (73.4–106.5)
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logistical barriers (e.g., traveling to the study center), and
unwillingness to participate in a research project.
Although short screening tools like MMSE [26] and
MoCA have a relatively high sensitivity and specificity
[25], they are not precise enough for diagnostic pur-
poses, especially in early stages of dementia [27]. Our
pilot trial therefore tested the feasibility of recruitment
through memory clinics, and not newspapers or general
mailing lists. Participant recruitment is a well-known
barrier to dementia research, and exploring the reasons
and ways to overcome these challenges is a priority [28,
29]. Similar to our study, a lack of interest and research
awareness and high number of comorbidities were the
major factors that challenged recruitment of older adults
with dementia in previous studies [28]. Prior trials of de-
mentia prevention strategies have recruited patients
from a combination of sources including memory clinics
from several different cities and dementia registers and
networks [9–11]. Compared to our study, recruitment in
those studies seemed more successful. However, recruit-
ment through dementia registers is not always possible
due to privacy reasons and limited possibilities to access
the registry. Another explanation for the higher recruit-
ment rates in previous studies might be that they had
multiple testing and training centers [9, 11]. The fact
that all our participants had to be willing and able to
attend our study center once weekly in case they got
randomized to Dalcroze eurhythmics training might
have been a barrier to successful recruitment.
Among the few participants recruited in our pilot trial,
retention rate was high with only one participant (5.5%)
dropping out of the study. However, adherence to the
study interventions was low for both the Dalcroze group
(56% adherence) and the SHEP group (62% adherence).
The main reason for non-adherence was forgetting
about the program or lack of motivation to leave home.
We think that the duration of each session for both pro-
grams was adequate although a 60-min Dalcroze session
might seem long for patients with cognitive impairment.
The 1-h duration of the Dalcroze sessions was chosen
based on a previous trial [19] and the previous experi-
ence of our investigator team and the eurhythmics in-
structors with Dalcroze classes in this population. Also,
lessons were targeted to the capabilities of each partici-
pant, and they had the possibility to sit down for the ex-
ercises when needed.
This study has several strengths. First, the study was of
high methodological quality regarding the comprehen-
sive testing applied at the memory clinics to diagnose
MCI or mild dementia, randomization, blinding, testing,
and analysis procedures. Second, the tests and question-
naires used in this study have been validated in the se-
nior population and previously applied in older adults
with cognitive impairment. Third, all participants have
been diagnosed with the same, high standard diagnostic
setting before they were enrolled. Nevertheless, the main
limitation of this study is that the high standard of diag-
nostic and enrollment criteria made the recruitment very
challenging and resulted in a small sample size. Also,
our results are not applicable to older adults who are ei-
ther cognitively healthy or affected by more severe stages
of dementia.
The challenges of recruitment and adherence led to
the conclusion that a trial testing a home versus a group
Table 2 Changes over time for gait speed and MoCA
Dalcroze (n = 7) SHEP (n = 4) Control (n = 6)
Change in single-task gait speed
Mean gait speed at baseline (95% CI) 103.3 (84.1, 122.6) 104.4 (65.2, 143.7) 112.0 (97.5, 126.5)
Mean change (95% CI) at 6 months − 11.4 (− 33.4, 10.6) 15.4 (− 14.3, 45.0) 5.0 (− 19.8, 29.8)
Mean change (95% CI) at 12 months − 10.0 (− 28.2, 8.3) 6.5 (− 18.3, 31.4) − 10.3 (− 31.2, 10.6)
Change in dual-task working memory
Mean gait speed at baseline (95% CI) 90.2 (72.7, 107.8) 114.5 (90.5, 138.4) 88.3 (70.2, 106.4)
Mean change (95% CI) at 6 months − 0.1 (− 32.0, 31.8) − 45.5 (− 60.0, − 19.1) − 15.3 (− 50.1, 19.4)
Mean change (95% CI) at 12 months − 0.9 (− 14.8, 13.1) − 39.5 (− 87.7, − 3.3) -26.1 (− 41.4, − 10.8)
Change in dual-task semantic memory
Mean gait speed at baseline (95% CI) 79.1 (61.8, 96.3) 114.0 (78.9, 149.1) 89.9 (73.4, 106.5)
Mean change (95% CI) at 6 months − 32.4 (− 71.3, 6.5) − 20.4 (− 73.0, 32.2) − 26.3 (− 64.1, 11.6)
Mean change (95% CI) at 12 months -16.4 (− 46.4, 13.6) − 26.7 (− 69.7, 16.3) − 22.2 (− 50.2, 5.8)
Changes in MoCA
Mean MoCA Score at baseline (95% CI) 19.6 (16.9, 22.2) 22.6 (18.9, 26.3) 20.0 (18.0, 21.2)
Mean change (95% CI) at 6 months 0.3 (− 2.0, 2.6) − 3.7 (− 6.9, − 0.5) − 0.6 (− 0.3, 1.9)
Mean change (95% CI) at 12 months − 1.0 (− 2.5, 0.5) − 1.7 (− 3.9, 0.4) 0.6 (− 1.0, 2.2)
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exercise program for patients with MCI or early demen-
tia is not feasible. Participants at an earlier stage in the
continuum of cognitive decline may be more likely to be
enrolled and motivated for preventive exercise interven-
tions. In fact, an ideal target population may be older
adults with subjective cognitive decline (SCD). SCD is a
preclinical state of dementia during which affected indi-
viduals already experience deterioration in their cogni-
tive function; however, the changes are not objectively
measurable [30]. SCD is an important risk factor for ob-
jective cognitive impairment such as MCI and dementia
[30], and the period between individuals first experience
SCD until they get diagnosed with MCI or dementia
could be considered a window of opportunity for early
interventions to prevent cognitive decline and falls. This
is supported by recent dementia research guidelines
which recommend to include participants with earlier
diagnostic disease stages before the full picture of de-
mentia is reached [31].
Conclusion
Given the challenges of recruitment and adherence
among community-dwelling patients with MCI or early
dementia, a more effective strategy for RCTs on exercise
interventions and cognitive health may be a focus on
older adults at an earlier state of cognitive decline. Con-
sequently, the definitive trial building on this pilot study
started recruitment in January 2018 (clinicaltrials.gov ID:
NCT03384602) targeting older adults with SCD.
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